Research
Identification of potential therapeutic targets in human head & neck squamous cell carcinoma
-
* Corresponding author: Raj K Puri raj.puri@fda.hhs.gov
1 Tumor Vaccines and Biotechnology Branch, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
2 Department of Scientific Laboratories, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
3 Mayo Clinic Cancer Center, 200 First Street Southwest, Rochester, Minnesota, 55905, USA
4 Department of Otorhinolaryngology, Head & Neck Surgery, School of Medicine, University of Maryland, Baltimore, MD 21201, USA
Head & Neck Oncology 2009, 1:27 doi:10.1186/1758-3284-1-27
Published: 14 July 2009Additional files
Additional file 1:
Gene expression changes in HNSCC compared to normal tonsils. Data show up-regulated genes, with p-value < 0.01 and log2 ratio ≥ 1, in HNSCC compared with normal tonsil tissues.
Format: DOC Size: 245KB Download file
This file can be viewed with: Microsoft Word Viewer
